CGRP vs Relaxin-3 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide produced by alternative splicing of the calcitonin gene in neurons. It is the most abundant neuropeptide in the sensory nervous system, expressed in trigeminal ganglion neurons and released from perivascular n...
Calculate CGRP dose →Relaxin-3 (also called INSL7) is the most ancient member of the insulin/relaxin superfamily and is expressed predominantly in the nucleus incertus (NI) of the brainstem, a structure implicated in stress, arousal, and hippocampal theta rhythm generation. Unlike relaxin-1 and relax...
Calculate Relaxin-3 dose →| Parameter | CGRP | Relaxin-3 |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | FDA Approved (Anti-CGRP antibodies) | Preclinical Research |
| Half-Life | ~7-10 min (plasma; native) | ~30-60 minutes (estimated) |
| Typical Dose | Anti-CGRP mAbs: 70-240 mg SC monthly or quarterly | 100-500 pmol ICV; 1-3 nmol/kg SC |
| Frequency | Monthly or quarterly (approved antibodies) | Single or twice daily (preclinical) |
| Route | Endogenous; IV/SC (research) | ICV, SC (preclinical) |
| FDA Status | Anti-CGRP antibodies approved (erenumab, fremanezumab, galcanezumab, eptinezumab) | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.